VARIANT II TURBO LINK Hemoglobin A1c Program Reorder Pack, 1600 tests. For the determination of Hemoglobin A1c in human whole blood. Contents: 1. Elution Buffer A, 1 x 2500 mL Bis-Tris Phosphate Buffer 2. Elution Buffer B, 1 x 2100 mL Bis-Tris Phosphate Buffer 3. Wash/Diluent Solution, 1 x 2500 mL, Deionized water 4. Cartridge set - 2 cations exchange Analytical Cartridges, 4 cation exchange guard cartridges 5. CD-ROM 1, CD Rom with program parameters 6. Calibrator/Diluent Set, 2 levels, 2 vials each of lyophilized human red blood cell hemolysate with preservative, 1 bottle of diluent, 100 mL deionized water. 7. Whole Blood Primer, 6 x 1 mL, Lyophilized human red blood cell hemolysate with preservative 8. Sample Vials, 2 x 100, Polypropylene vials with pierceable lids 9. Instruction Manual. Percentage determination of hemoglobin A1c in human whole blood using ion-exchange high=performance liquid chromatography (HPLC) Made in United States. Bio-Rad Laboratories, Hercules, CA 94547.
- Company
- Bio-Rad Laboratories Inc
- Recall Initiated
- September 12, 2011
- Posted
- October 7, 2011
- Terminated
- May 11, 2012
- Recall Number
- Z-0027-2012
- Quantity
- 40
- Firm Location
- Hercules, CA
Reason for Recall
A previous recall related to reports of calibration failure and late retention times using Elution Buffer led to an examination of other buffers manufactured during the same time period and a decision was made to field correct these products until a definitive root cause and corrective action have been found and implemented.
Distribution
Nationwide and to New Zealand, Canada, France, England, China, India, Mexico, Italy, Brazil, Australia, Singapore, Thailand, SriLanka, hong Kong, Sweden, Germany, Peru, Jamaica, Uruguay, Columbia, Argentina, Chile, Paraguay and Korea.
Lot / Code Info
Model number: 270-2716; Lot number 70210702, 9/30/11. Contains Buffer lot number GA10429/GA10430, expiry 2/28/12.
Root Cause
Process control
Action Taken
Bio-Rad sent an Urgent Medical Device Correction letter on September 12, 2011, to all affected subsidiaries and customers. The letter identified the product, the problem, and the action to be taken by the customer. Customers were instructed to discard all affected product in accordance with all local, state and federal disposal procedures. If customers distributed the product further they should direct their customers to discard all unused product. Customers were asked to please translate (if necessary) the attached "Customer Medical Device Correction Response Form," customers should add their local contact information and distribute to all affected customers in their region by mail or fax. Compile tracking documentation (e.g. Excel spreadsheet) for all customers who received the Medical Device Correction Letter. Complete the "SUBSIDIARY MEDICAL DEVICE CORRECTION RESPONSE FORM" and fax to Bio-Rad Regulatory Affairs at (510) 741-3954, or e-mail PDF to CSD_RA/Hercules/US/BIO-RAD. Customers would be issued credits for the affected products based on their request. For questions call (510) 741-3954.